PTGS2 and depressive symptom measurement: More importantly, we demonstrate here that an upregulation of βCaMΚΙΙ in CA1 significantly enhanced the activity of the COX-2/PGE2 pathway and was sufficient to produce a distinct array of core symptoms of depression.